Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Everyday Health, Inc.
Report date December 03, 2016 · Filed December 06, 2016
Section 16 reporting ended · disclosed 2016-12-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2016-12-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-12-03 · Other · Disposed 3,007 · Balance 17,374 F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). Row 2 · 2016-12-05 · Disposition to issuer · Disposed 17,374 · Balance 0 F2: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 17,374 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").
F2: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 17,374 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding).
Teladoc Health, Inc.
Report date August 01, 2024 · Filed August 05, 2024
Section 16 reporting ended · disclosed 2024-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,929 |
Ending reported balance
After 2024-08-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-08-01 · Exercise / conversion · Acquired 20,198 · Balance 110,808 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-02 · Sale · Disposed 10,879 · Balance 99,929 F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 100,994 |
Reported balance
After 2024-08-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-01 · Exercise / conversion · Disposed 20,198 · Balance 100,994 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2024 Filed Aug 5, 2024 20:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,879 | $8.14 | $88,576.82 |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,929 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 20,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · derivative · entry 3 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,994 Underlying: Common Stock · 20,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,812 | $11.16 | $53,687.48 |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · nonDerivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,610 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · derivative · entry 5 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,829 Underlying: Common Stock · 6,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 83,705 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 83,705 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · derivative · entry 4 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,642 Underlying: Common Stock · 2,377 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 28,527 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 28,527 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,411 | $12.69 | $132,094.77 |
DisclosureSEC source: 0001477449-24-000107 · wk-form4_1714680360.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,070 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 20,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000107 · wk-form4_1714680360.xml · derivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,192 Underlying: Common Stock · 20,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000107 · wk-form4_1714680360.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 102,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000069 · wk-form4_1710965418.xml · derivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,100 Underlying: Common Stock · 102,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 18,349 | $14.52 | $266,354.08 |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · nonDerivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,283 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 27,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · derivative · entry 6 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,804 Underlying: Common Stock · 27,901 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 83,705 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F8 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 83,705 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 9,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · derivative · entry 5 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,019 Underlying: Common Stock · 9,508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 28,527 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 28,527 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 28,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · derivative · entry 4 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,527 Underlying: Common Stock · 28,527 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 27,901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000049 · wk-form4_1709673081.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 02, 2024 Filed Feb 2, 2024 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,882 | $19.18 | $151,161.00 |
DisclosureSEC source: 0001477449-24-000011 · wk-form4_1706911445.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,223 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 20,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000011 · wk-form4_1706911445.xml · derivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,390 Underlying: Common Stock · 20,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000011 · wk-form4_1706911445.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 35,887 | $17.05 | $611,729.80 |
DisclosureSEC source: 0001477449-23-000070 · wk-form4_1699045983.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,907 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 80,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000070 · wk-form4_1699045983.xml · derivative · entry 3 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,588 Underlying: Common Stock · 80,794 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 80,794 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000070 · wk-form4_1699045983.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 83,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004416 · form4-03072023_090328.xml · derivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,705 Underlying: Common Stock · 83,705 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 20:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 242,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010991 · form4-11022022_011106.xml · derivative · entry 1 Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,382 Underlying: Common Stock · 242,382 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on November 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on November 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 17:45 UTC | Everyday Health, Inc. EVDY · Entity 180558 | Disposition to issuerCommon Stock | 17,374 | $10.50 | $182,427.00 |
DisclosureSEC source: 0001209191-16-153723 · doc4.xml · nonDerivative · entry 2 Kornwasser Laizer · CIK 0001387813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 17,374 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). F2 · price: Pursuant to the terms of the award, the vesting of restricted stock units for an aggregate of 17,374 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). Read SEC document |
| December 03, 2016 Filed Dec 6, 2016 17:45 UTC | Everyday Health, Inc. EVDY · Entity 180558 | OtherCommon Stock | 3,007 | $10.50 | $31,573.50 |
DisclosureSEC source: 0001209191-16-153723 · doc4.xml · nonDerivative · entry 1 Kornwasser Laizer · CIK 0001387813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,374 F1 · kind: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). F1 · price: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.